News
Scottish Brain Sciences is part of a global network of Brain Health organisations focussing on different aspects of developing knowledge, understanding and interventions to turn the tide on brain diseases and acquired brain disorders.
In this section we not only include our own news but also updates, reports, insights and commentaries on the work of other research teams, clinicians, policymakers, and people affected by brain ill health.
Stress Awareness Month at Scottish Brain Sciences
April is Stress Awareness Month, and the theme for 2024 is “Little by Little,” so let’s take a closer look…
The SBS Blog – Welcome our new Head of Impact and Innovation!
We are thrilled to be able to welcome Anna Borthwick to the SBS Team as Head of Impact and Innovation! Read more about what she brings to Scottish Brain Sciences…
Hope for the future in dementia research
Read here for an insight from the STV News show, Scotland Tonight, with our CEO and Founder, Prof Craig Ritchie, about the lifechanging potential for research to help detect Alzheimer’s early & treat before it progresses to dementia.
The SBS Blog – Welcome our new Chief Investigator!
Please join us in welcoming Dr Sarah Gregory to the SBS Team as IONA National Coordinator! Read more about what she brings to Scottish Brain Sciences…
Scottish Brain Sciences position on the use of blood-based biomarkers…
Our CEO and Founder, Prof Craig Ritchie, weighs in on blood-based biomarkers for Alzheimer’s disease being openly available to the public in the U.S.
The SBS Blog – Welcome our new Senior Clinical Investigator!
We are thrilled to be able to welcome Dr Clara Russell to the SBS Team as Senior Clinical Investigator! Read more about what she brings to Scottish Brain Sciences…
Profile: Dr Stephanie Adams
At the intersection of Sport Science and Psychology: meet Scottish Brain Sciences’ Head of Sports Science.
© angellodeco Partnership seeks early Alzheimer’s blood test
An agreement between Scottish Brain Sciences and a global leader in precision diagnostics is aiming to transform the ability of clinicians to identify the very earliest signs of Alzheimer’s Disease – long before symptoms can be seen.
